$13.14
+0.14 (+1.08%)
Open$13.34
Previous Close$13.00
Day High$13.69
Day Low$13.05
52W High$14.05
52W Low$9.75
Volume—
Avg Volume1.18M
Market Cap332.10M
P/E Ratio18,955.41
EPS$0.02
SectorN/A
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 194.29M | 181.07M | 168.52M |
| Net Income | 10.21M | 11.79M | 9.66M |
| Profit Margin | 5.3% | 6.5% | 5.7% |
| EBITDA | 19.20M | 19.98M | 18.03M |
| Free Cash Flow | 12.92M | 16.57M | 11.29M |
| Rev Growth | -2.8% | +2.5% | +6.9% |
| Debt/Equity | 0.50 | 0.48 | 0.48 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.66 | -0.60% | — | 4.19B |
| PICS | Pics Nv | $10.63 | -0.09% | 6.1 | 1.37B |
| DMII | Drugs Made In America Acquis | $10.09 | +0.40% | 74.6 | 640.19M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.67 | -0.19% | 35.3 | 334.79M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.10% | 57.5 | 591.76M |